Skip to main content
BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
11.70
+0.32 (2.81%)
Apr 23, 2025, 3:50 PM EDT

BioStem Technologies Revenue

In the year 2024, BioStem Technologies had annual revenue of $301.83M with 1,708.93% growth. BioStem Technologies had revenue of $102.87M in the quarter ending December 31, 2024, with 799.11% growth.

Revenue
301.83M
Revenue Growth
+1,708.93%
P/S Ratio
0.65
Revenue / Employee
9.15M
Employees
33
Market Cap
195.43M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024301.83M285.14M1,708.93%
Dec 31, 202316.69M9.81M142.69%
Dec 31, 20226.88M2.53M58.38%
Dec 31, 20214.34M4.03M1,284.88%
Dec 31, 2017313.45K-293.78K-48.38%
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro
Dec 31, 2010 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SS Innovations International 20.65M
Endo Inc. 1.76B
Veradigm 588.02M
Northwest Biotherapeutics 1.38M
Elite Pharmaceuticals 70.00M
Glass House Brands 200.90M
American Oncology Network 1.76B
Longduoduo Company 6.01M
Revenue Rankings

BioStem Technologies News

More News